American Philosophical Society Presents John Scott Awards

Three scientists with Pennsylvania roots receive honors for breakthroughs in drug discovery and human understanding.

Updated on Oct. 27, 2026 in Science — General

A bronze medallion and glass chemistry flasks on an oak desk in a scholarly library setting, representing academic medical research.
The American Philosophical Society awarded the John Scott Award to Nina Jablonski, Magid Abou-Gharbia, and Daniel Skovronsky for their significant contributions to scientific innovation. AI Illustration. Upload story photo >

Live Poll

Should scientific awards prioritize researchers who work in the local region?

The American Philosophical Society awarded the prestigious John Scott Award to Nina Jablonski, Magid Abou-Gharbia, and Daniel Skovronsky. Each recipient was honored for their significant contributions to human welfare and scientific innovation.

Why it matters

The awards highlight the impact of regional researchers in Pennsylvania, New Jersey, and Delaware whose work advances global medical understanding. These recipients exemplify how dedicated academic and corporate research can directly improve the comfort and happiness of mankind.

The committee selects winners based on achievements that foster public welfare, with Magid Abou-Gharbia notably holding 145 U.S. patents. The selection process specifically prioritizes researchers working within the Pennsylvania, New Jersey, and Delaware region.

The players

Nina Jablonski

She is a professor at Penn State University recognized for her contributions to human understanding.

Magid Abou-Gharbia

He is a professor at Temple University who holds 145 U.S. patents and has discovered 10 marketed drugs.

Daniel Skovronsky

He is an executive at Eli Lilly and Company who previously founded the medical research firm Avid Radiopharmaceuticals.

American Philosophical Society

This Philadelphia-based organization is a historic learned society that presents the John Scott Award.

The details

Recipients include Nina Jablonski from Penn State, Temple University professor Magid Abou-Gharbia, and Eli Lilly executive Daniel Skovronsky. Skovronsky is credited with founding Avid Radiopharmaceuticals, which developed the FDA-approved Alzheimer's diagnostic tool Amyvid.

Timeline

  1. 1974: Magid Abou-Gharbia arrived in Philadelphia for his doctoral studies.

  2. 2008: Magid Abou-Gharbia returned to the academic sector.

  3. 2010: Eli Lilly completed its acquisition of Avid Radiopharmaceuticals.

  4. October 2026: The American Philosophical Society presented the John Scott Awards.

The Big Picture

The ceremony serves as an extension of the John Scott Award's mandate to honor life-changing scientific advancements. By highlighting these three specific researchers, the Society reinforces its long-standing commitment to recognizing regional excellence in drug discovery and human science.

The work conducted by these researchers, such as the development of Alzheimer's diagnostic tools, directly influences the future availability of clinical treatments. Local residents benefit from the concentration of high-level pharmaceutical research within Pennsylvania universities and corporate hubs.

The takeaway

The recognition of these researchers emphasizes the critical role that localized scientific investment plays in global health outcomes. Readers can track how regional academic partnerships frequently serve as the foundation for life-saving medical breakthroughs.

Further reading

Learn more about local scientific developments at the Philadelphia Science — General page.

Source note: This article includes information reported by The Philadelphia Inquirer.

Live Poll

Should scientific awards prioritize researchers who work in the local region?